EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Clonal Hematopoiesis in Colorectal Cancer: Mechanisms and Implications

Chenyue Xia, Yi Lu, Jinhui Gu iD

Cancer Medicine · 2026

DOI: 10.1002/cam4.72151 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2026. Verfasst von Chenyue Xia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Colorectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Suzhou Municipal Key Clinical Disease Diagnosis and Treatment Technology Special Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clonal hematopoiesis (CH) arises from the expansion of hematopoietic stem and progenitor cells bearing somatic mutations, often in genes linked to epigenetic regulation and inflammation. Once considered a benign age‐related phenomenon, CH has gained increasing attention for its potential to influence cancer biology beyond hematologic malignancies. Recent studies have uncovered an unexpectedly high prevalence of CH in patients with colorectal cancer (CRC), raising important questions about its origin, context‐specific drivers, and pathological consequences. While cytotoxic therapies are known contributors, accumulating evidence suggests that the chronic inflammatory and metabolic alterations intrinsic to CRC may also shape hematopoietic clonality. In turn, CH‐derived myeloid cells harboring mutations such as DNMT3A or TET2 can modulate the tumor microenvironment, promote inflammation, and impair antitumor immunity. In this review, we synthesize emerging findings on the bidirectional relationship between CH and CRC, highlighting the mechanistic underpinnings and potential implications for disease progression, therapeutic resistance, and immune modulation. Understanding this evolving interface may open new avenues for risk stratification and treatment personalization in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisColorectal NeoplasmsHumansTumor MicroenvironmentMutationDNA Methyltransferase 3ADioxygenasesDNA (Cytosine-5-)-MethyltransferasesAnimalsHematopoietic Stem CellsEpigenesis, GeneticDNA-Binding Proteins

Stichwörter der Autor:innen

clonal hematopoiesiscolorectal cancerhematopoietic stem cellssomatic mutationstumor microenvironment

Substanzen

DNA Methyltransferase 3ADioxygenasesDNA (Cytosine-5-)-MethyltransferasesTET2 protein, humanDNMT3A protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Anorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, Jiangsu, China.

ORCID-Profile: Jinhui Gu

Förderung

  • Suzhou Municipal Key Clinical Disease Diagnosis and Treatment Technology Special Project

Zitieren

APA

Xia, C., Lu, Y., & Gu, J. (2026). Clonal Hematopoiesis in Colorectal Cancer: Mechanisms and Implications. Cancer Medicine. https://doi.org/10.1002/cam4.72151

Vancouver

Xia C, Lu Y, Gu J. Clonal Hematopoiesis in Colorectal Cancer: Mechanisms and Implications. Cancer Medicine. 2026. doi:10.1002/cam4.72151

BibTeX
@article{Xia2026,
  author = {Xia, Chenyue and Lu, Yi and Gu, Jinhui},
  title = {Clonal Hematopoiesis in Colorectal Cancer: Mechanisms and Implications},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.72151}
}
Kostenlos starten →